[Angiotensin I receptor blockers for heart failure].

Abstract

Angiotensin conversion enzyme inhibitors (ACE-inhibitors) have long been the only possibility to influence the renin angiotensin system (RAS) and its often fatal influences in heart failure. In the last few years specific blockers of the angiotensin 1 receptor (AT I blockers) offered a new possibility for this therapeutic target. In contrast to ACE inhibitors AT I blockers are relatively new and, therefore, few data on heart failure are available. The first head-to-head studies that compared AT I blockers and ACE-inhibitors and their effect on mortality did not show a reduced mortality in the AT I blocker groups. Based on the available data AT I blockers should be used in heart failure patients who are intolerant of ACE-inhibitors.

• Authors: F M Fruhwald, E Kickenweiz, R Zweiker, W Klein
• Journal: Wiener medizinische Wochenschrift (1946) (Wien Med Wochenschr) Vol. 151 Issue 7-8 Pg. 157-9 ( 2001) ISSN: 0043-5341 [Print] Austria
• Vernacular Title: AT-I-Rezeptor-Blocker bei Herzinsuffizienz.
• PMID: 11450163 (Publication Type: Journal Article, Review)

Chemical References

• Angiotensin Receptor Antagonists
• Angiotensin-Converting Enzyme Inhibitors
• Antihypertensive Agents
• Benzimidazoles
• Biphenyl Compounds
• Receptor, Angiotensin, Type 1
• Receptor, Angiotensin, Type 2
• Tetrazoles
• Valsartan
• Valine
• Losartan
• candesartan

Topics

• Angiotensin Receptor Antagonists
• Angiotensin-Converting Enzyme Inhibitors (adverse effects, therapeutic use)
• Antihypertensive Agents (therapeutic use)
• Austria
• Benzimidazoles (therapeutic use)
• Biphenyl Compounds
• Contraindications
• Cough (chemically induced, prevention & control)
• Drug Therapy, Combination
• Heart Failure (drug therapy, mortality)
• Humans
• Losartan (therapeutic use)
• Practice Guidelines as Topic
• Randomized Controlled Trials as Topic
• Receptor, Angiotensin, Type 1
• Receptor, Angiotensin, Type 2
• Tetrazoles (therapeutic use)
• Valine (analogs & derivatives, therapeutic use)
• Valsartan